GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years. We prevent and treat disease with vaccines, specialty and general medicines. We focus on science of the immune system, human genetics, and advanced technologies investing in 4 core therapeutic areas and future opportunities to impact health at scale. We operate responsibly for all our stakeholders by prioritising Innovation, Performance and Trust.

Our culture: Ambitious for patients to deliver what matters better and faster. Accountable for impact with clear ownership and support to succeed. Do the right thing with integrity and care because people count on us. Vaccines at a glance: We have more than 20 vaccines to help protect people from a range of diseases throughout their lives. We supply vaccines to people living in over 160 countries. Almost 17,000 GSK people around the globe work on vaccines. We have 21 vaccine candidates in our pipeline as we seek to develop new vaccines against infectious diseases.